Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
75 GBX | 0.00% |
|
-5.06% | -34.78% |
May. 23 | Celadon Pharmaceuticals plc Announces Supply of Products to New US Customer | CI |
May. 14 | Celadon Pharmaceuticals Plc Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 27
Managers
Managers | Title | Age | Since |
---|---|---|---|
James Short
FOU | Founder | 55 | 17-12-31 |
Jonathan Turner
DFI | Director of Finance/CFO | 46 | 23-01-16 |
Iqbal Gill
CTO | Chief Tech/Sci/R&D Officer | - | 21-12-31 |
Burleigh Abbott
PRN | Corporate Officer/Principal | - | - |
Kerin Williams
SEC | Corporate Secretary | 46 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Firth
BRD | Director/Board Member | 62 | 18-09-16 |
Ian Anton
CHM | Chairman | 64 | 22-03-27 |
Robert Barr
BRD | Director/Board Member | 65 | 22-03-27 |
Steven Hajioff
BRD | Director/Board Member | 58 | 22-03-27 |
Jonathan Turner
DFI | Director of Finance/CFO | 46 | 23-01-16 |
James Short
FOU | Founder | 55 | 17-12-31 |
Director/Board Member | 59 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 65,982,712 | 20,928,889 ( 31.72 %) | 0 | 31.72 % |
Company contact information
![address Celadon Pharmaceuticals Plc(CEL)](https://cdn.zonebourse.com/static/address/46736800.png)
Sector
![Consensus](/images/consensus_flch.gif)
1st Jan change | Capi. | |
---|---|---|
-34.78% | 63.17M | |
+56.95% | 809B | |
+39.52% | 624B | |
-6.88% | 351B | |
+7.50% | 289B | |
+13.74% | 240B | |
+13.83% | 220B | |
-0.49% | 219B | |
+7.77% | 166B | |
-2.68% | 157B |
- Stock Market
- Equities
- CEL Stock
- Company Celadon Pharmaceuticals Plc